Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections

被引：3
|
作者：
Arsuffi, Stefania [1 ,2 ]
Sansone, Emanuele [2 ,3 ]
Foca, Emanuele [1 ,2 ]
Storti, Samuele [1 ,2 ]
Diaferia, Teresa [2 ,3 ]
Bonfanti, Carlo [2 ,4 ]
Terlenghi, Luigina [2 ,4 ]
Caruso, Arnaldo [2 ,4 ]
Sala, Emma [2 ,3 ]
Castelli, Francesco [1 ,2 ]
De Palma, Giuseppe [2 ,3 ]
Quiros-Roldan, Eugenia [1 ,2 ]
机构：
[1] Univ Brescia, Unit Infect & Trop Dis, Brescia, Italy
[2] ASST Spedali Civili Hosp, Brescia, Italy
[3] Univ Brescia, Dept Occupat Hlth & Ind Hyg, Brescia, Italy
[4] Univ Brescia, Microbiol Dept, Brescia, Italy
来源：
ISCIENCE | 2023年 / 26卷 / 01期
关键词：
HEALTH-CARE WORKERS; COVID-19; ANTIBODY;
D O I：
10.1016/j.isci.2023.106716
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
COVID-19 vaccines elicit a strong anti-S antibodies response. We aim to describe antibody titers in peri-vaccination SARS-CoV-2 infections. This is a retrospective longitudinal single-cohort study. Serological tests were performed at the time of the first SARS-CoV-2 vaccine dose (T0) and 60 (T1), 120 (T2), and 240 (T3) days after. The study included 4,682 subjects. Group A had the infection without an anti-S Ig response. Group B and C seroconverted for anti-N Ig between T0 and T1 and be-tween T1 and T2, respectively. Group D was persistently anti-N Ig negative. Group B showed an initial sub-optimal response, reaching the highest titer at T3. Those who received the second dose 120 days after the infection had higher titers compared to those who received it 21 days after the first dose. The immune response depends on the number and the timing of vaccine doses, highlighting the need for a more personalized approach to vaccination.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] Trends and Correlates of Breakthrough Infections With SARS-CoV-2
    Yamal, Jose-Miguel
    Appana, Savitri
    Wang, Mengxi
    Leon-Novelo, Luis
    Bakota, Eric
    Ye, Yuanqing
    Sharma, Shreela
    Morrison, Alanna C.
    Marko, Dritana
    Linder, Stephen H.
    Rector, Alison
    Jetelina, Katelyn K.
    Boerwinkle, Eric
    de Oliveira Otto, Marcia
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [22] SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
    Regenhardt, Elisa
    Kirsten, Holger
    Weiss, Melanie
    Luebbert, Christoph
    Stehr, Sebastian N.
    Remane, Yvonne
    Pietsch, Corinna
    Hoenemann, Mario
    von Braun, Amrei
    VACCINES, 2023, 11 (05)
  • [23] Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
    Kuhlmann, Constanze
    Mayer, Carla Konstanze
    Claassen, Mathilda
    Maponga, Tongai
    Burgers, Wendy A.
    Keeton, Roanne
    Riou, Catherine
    Sutherland, Andrew D.
    Suliman, Tasnim
    Shaw, Megan L.
    Preiser, Wolfgang
    LANCET, 2022, 399 (10325): : 625 - 626
  • [24] Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India
    Singh, Urvashi B.
    Rophina, Mercy
    Chaudhry, Rama
    Senthivel, Vigneshwar
    Bala, Kiran
    Bhoyar, Rahul C.
    Jolly, Bani
    Jamshed, Nayer
    Imran, Mohamed
    Gupta, Ritu
    Aggarwal, Praveen
    Divakar, Mohit K.
    Sinha, Subrata
    Arvinden, V. R.
    Bajaj, Anjali
    Shamnath, Afra
    Jain, Abhinav
    Scaria, Vinod
    Sivasubbu, Sridhar
    Guleria, Randeep
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1696 - 1700
  • [25] SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care
    Wang, Lindsey
    Wang, William
    Xu, Rong
    Berger, Nathan A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (03)
  • [26] Immune response scenario and vaccine development for SARS-CoV-2 infection
    Mohammad, Mai H. S.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 94
  • [27] Emerging Vaccine-Breakthrough SARS-CoV-2 Variants
    Wang, Rui
    Chen, Jiahui
    Hozumi, Yuta
    Yin, Changchuan
    Wei, Guo-Wei
    ACS INFECTIOUS DISEASES, 2022, 8 (03): : 546 - 556
  • [28] SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis
    Manley, Harold J.
    Li, Nien Chen
    Aweh, Gideon N.
    Hsu, Caroline M.
    Weiner, Daniel E.
    Miskulin, Dana
    Harford, Antonia M.
    Johnson, Doug
    Lacson, Eduardo, Jr.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : 406 - 415
  • [29] Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
    Servellita, Venice
    Syed, Abdullah M.
    Morris, Mary Kate
    Brazer, Noah
    Saldhi, Prachi
    Garcia-Knight, Miguel
    Sreekumar, Bharath
    Khalid, Mir M.
    Ciling, Alison
    Chen, Pei-Yi
    Kumar, G. Renuka
    Gliwa, Amelia S.
    Nguyen, Jenny
    Sotomayor-Gonzalez, Alicia
    Zhang, Yueyuan
    Frias, Edwin
    Prostko, John
    Hackett, John, Jr.
    Andino, Raul
    Wadford, Debra A.
    Hanson, Carl
    Doudna, Jennifer
    Ott, Melanie
    Chiu, Charles Y.
    CELL, 2022, 185 (09) : 1539 - +
  • [30] Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
    Farinholt, Timothy
    Doddapaneni, Harsha
    Qin, Xiang
    Menon, Vipin
    Meng, Qingchang
    Metcalf, Ginger
    Chao, Hsu
    Gingras, Marie-Claude
    Ayadhanula, Vasanthi
    Farinholt, Paige
    Agrawal, Charu
    Muzny, Donna M.
    Piedra, Pedro A.
    Gibbs, Richard A.
    Petrosino, Joseph
    BMC MEDICINE, 2021, 19 (01)
12345